Chiang John 4

What Happened
John Chiang, a director of Astrana Health, received a grant of 4,525 restricted shares of common stock on June 10, 2026. The shares were granted at $0.00 (transaction code A — award/grant). The grant carries vesting conditions and therefore is not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-10; Form filed: 2026-06-12 (timely filing).
• Transaction type/code: Award/Grant (A).
• Shares granted: 4,525 restricted shares; acquisition price reported as $0.00.
• Vesting: Shares vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders (per footnotes).
• Shares owned after transaction: Not separately disclosed in the filing beyond the inclusion of the 4,525 restricted shares.
• No 10b5-1 plan, tax-withholding sale, or sale-of-shares reported in this filing.

Context
This was a restricted stock award to a board member rather than a market purchase or sale. Restricted grants are common for director compensation and are subject to vesting conditions, so they do not necessarily indicate immediate buying or selling intent.